Skip to main content
Caplight Logo









ZXBio, Inc.

ZXBio, Inc.

Private
HuzhouHealthcare & Life Scienceshttps://zxbiopharm.com/

Last Round

Series A

Extension

Nov 6, 2024

Total Funding Raised

$2.17M

Company Overview

ZXBio, Inc. is a biotechnology company that develops and produces monoclonal antibodies, antibody-based research and diagnostic reagents, and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

monoclonal antibodiesflow cytometrydiagnostic kitsIVDin vitro diagnosticdiagnostic reagentsclinical diagnosticslab reagentsclinical laboratory servicesdiagnostic hardwarebiotech manufacturinglab testingdomestic substitutionantibody production

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZXBio, Inc. Comparables

Compare ZXBio, Inc. with similar companies based on industry and business-model similarity.

ZXBio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing Challen Biotechnology Co., Ltd.
84%
Zybio Inc.
79%
Elabscience Biotechnology Co.,Ltd
78%

ZXBio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 6, 2024
Series A ExtensionOct 7, 2023
Series AJun 9, 2022
AngelSep 1, 2020
GrantSep 1, 2020

Key People

Founding team and executive leadership

Yang Zhang

Chairperson & CEO

Executive Team

ZXBio, Inc. Investors

Notable investors and investment history

ZXBio, Inc. investors
InvestorRounds
Huiyu Investment (Huizhi Group)Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 6, 2024

    Huiyu Investment (Huizhi Group) participated in the round.

  • Jun 9, 2022

    Raised Series A round with Zhejiang Orient Gene Biotech Co Ltd.

ZXBio, Inc. Filings

Explore SEC and related filing metadata, where available.

ZXBio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ZXBio, Inc.'s valuation, stock price, and market status.

Is ZXBio, Inc. a public or private company?

ZXBio, Inc. is a private company.

What is the current stock price of ZXBio, Inc.?

ZXBio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is ZXBio, Inc. worth (valuation)?

Valuation information for ZXBio, Inc. is not publicly available.

Can I buy ZXBio, Inc. stock?

ZXBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ZXBio, Inc.'s last funding round?

ZXBio, Inc.'s most recent funding round was Series A Extension on November 6, 2024.

Who are the main investors in ZXBio, Inc.?

Investor information for ZXBio, Inc. is not publicly disclosed.

Will ZXBio, Inc. IPO soon?

No public IPO plans have been announced for ZXBio, Inc..

How can I track ZXBio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZXBio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHuzhou
Employee Range2
Year Founded2017
Last FundingNov 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?